tiprankstipranks
Apellis Pharmaceuticals (APLS)
:APLS
US Market
Want to see APLS full AI Analyst Report?

Apellis Pharmaceuticals (APLS) Technical Analysis

1,007 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Apellis Pharmaceuticals’s (APLS) Moving Averages Convergence Divergence (MACD) indicator is 1.46, suggesting Apellis Pharmaceuticals is a Buy.
Apellis Pharmaceuticals’s (APLS) 20-Day exponential moving average is 40.31, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.
Apellis Pharmaceuticals’s (APLS) 50-Day exponential moving average is 35.83, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.

Apellis Pharmaceuticals (APLS) Pivot Points

May 21, 2026, 03:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
40.98
41.00
41.02
41.04
41.06
41.08
41.10
Fibonacci
41.00
41.02
41.03
41.04
41.06
41.07
41.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Apellis Pharmaceuticals (APLS) Moving Averages

May 21, 2026, 03:52 PM
Period
Simple
Exponential
MA5
41.03Buy
41.03Sell
MA10
41.04Sell
41.00Buy
MA20
40.99Buy
40.31Buy
MA50
34.04Buy
35.83Buy
MA100
28.30Buy
31.15Buy
MA200
26.26Buy
27.48Buy
Apellis Pharmaceuticals’s (APLS) 10-Day exponential moving average is 41.00, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.
Apellis Pharmaceuticals’s (APLS) 100-Day exponential moving average is 31.15, while Apellis Pharmaceuticals’s (APLS) share price is $40.9, making it a Buy.
Apellis Pharmaceuticals’s (APLS) stock price is $40.9 and Apellis Pharmaceuticals’s (APLS) 50-day simple moving average is 34.04, creating a Buy signal.
Apellis Pharmaceuticals’s (APLS) stock price is $40.9 and Apellis Pharmaceuticals’s (APLS) 100-day simple moving average is 28.30, creating a Buy signal.
Apellis Pharmaceuticals’s (APLS) stock price is $40.9 and Apellis Pharmaceuticals’s (APLS) 200-day simple moving average is 26.26, creating a Buy signal.

Apellis Pharmaceuticals (APLS) Technical Indicators

May 21, 2026, 03:52 PM
Name
Value
Implied Action
RSI (14)
84.47
Sell
STOCH (9,6)
46.57
Neutral
STOCHRSI (14)
47.62
Neutral
MACD (12,26)
1.46
Buy
ADX (14)
73.79
Sell
Williams %R
-52.38
Buy
CCI (14)
68.02
Neutral
ATR (14)
0.26
-
Ultimate Oscillator
29.78
Sell
ROC
0.20
Buy
Apellis Pharmaceuticals’s (APLS) Relative Strength Index (RSI) is 84.47, creating a Sell signal.
Apellis Pharmaceuticals’s (APLS) Trend Strength Indicator (ADX) is 73.79, creating a Sell signal.
Apellis Pharmaceuticals’s (APLS) Commodity Channel Index (CCI) is 68.02, creating a Neutral signal.
Apellis Pharmaceuticals’s (APLS) Price Rate of Change (ROC) is 0.20, creating a Buy signal.

FAQ

Is APLS a Buy, Hold, or Sell?
Based on APLS’s technical indicators, APLS is a Buy.
    What is APLS’s RSI (14)?
    APLS’s RSI (14) is 84.47, which suggests APLS is a Sell.
      What is APLS’s MACD?
      APLS’s MACD is 1.46, which suggests APLS is a Buy.
        What is APLS’s 5-day moving average?
        APLS’s 5-day moving average is 41.03, which suggests APLS is a Buy.
          What is APLS’s 20-day moving average?
          APLS 20-day moving average is 40.99, which suggests APLS is a Buy.
            What is APLS’s 50-day moving average?
            APLS’s 50-day moving average is 34.04, which suggests APLS is a Buy.
              What is APLS’s 200-day moving average?
              APLS’s 200-day moving average is 26.26, which suggests APLS is a Buy.
                What is APLS’s Williams % R (14)?
                APLS’s Williams % R (14) is -52.38, which suggests APLS is a Buy.
                  What is APLS’s CCI (14)?
                  APLS’s CCI (14) is 68.02, which suggests APLS is a Neutral.